Skip to content

Neurofeedback Rehabilitation Based on Motor Imaging in Patients in the Immobilization Phase

Neurofeedback Rehabilitation Based on Motor Imaging in Patients in the Immobilization Phase

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03545451
Acronym
REMINARY
Enrollment
30
Registered
2018-06-04
Start date
2018-10-03
Completion date
2021-06-30
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects, Patients With Amyotrophic Lateral Sclerosis, Patients With Shoulder Surgery

Keywords

EEG, neurofeedback, fMRI, ALS, surgery, upper limbs

Brief summary

As the prevalence of motor impairment increases with age, the proportion of the population affected by physical limitations is likely to increase in the coming years, considering that one in three people will be over 60 in 2050 (compared to one in five in 2005, INSEE projections). The possibility of reducing recovery time and / or improving the improvement of motor deficits is today a public health issue. The possibility of developing new therapeutic tools using innovative motor imaging rehabilitation technologies is an opportunity to offer rehabilitation adapted to specific disorders, personalized in relation to the patient's performance, and in continuity with the therapist. In this research project, we will use the principle of neurofeedback rehabilitation (EEG) based on motor imaging with a brain-computer interface. Feedback will consist of therapeutic video games.Here, we will test the feasibility of such approach in 10 healthy subjects, 10 patients with amyotrophic lateral sclerosis and 10 patients with uppel shoulder surgery.

Interventions

DEVICEVideogames

Videogames

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

Common to the 3 populations concerned: * patients or subjects of both sexes; * age: 18-70 years; * ability to give consent in writing; * Health Insurance. a) SLA: * patients with amyotrophic lateral sclerosis (defined according to the El Escorial criteria: possible, probable or definite), at the time of diagnosis; * Percentage of forced vital capacity (FVC) ≥ 65% of the predicted value for age, gender and size. b) Patients after a shoulder trauma: patients with scheduled shoulder surgery. c) Healthy subjects.

Exclusion criteria

* Dementia (MMSE score \<24/30) * Pregnancy or patient not having effective contraception. * Other neurological, psychiatric or orthopedic disease leading to a motor handicap or an inability to correctly realize the experimental paradigm: interfering with the evaluation of the movements of the upper limb, incapacity to realize the mental imagery of the movement. * Visual impairment resulting in an inability to properly view the computer screen. * History of epilepsy or active epilepsy. * Contraindication to MRI: cardiac or neuronal simulator, ferromagnetic surgical clips, implants and metal objects, intraocular foreign bodies, claustrophobia * Persons under guardianship, trusteeship or any other administrative or judicial measure of deprivation of rights and liberty * Subject in the exclusion period of another interventional research or participating in any other interventional research or therapeutic trial * Presence of another severe progressive pathology

Design outcomes

Primary

MeasureTime frameDescription
Performanceweek 1total displacement fo the avatar within the game

Secondary

MeasureTime frameDescription
electroencephalography activityweek 1, 2, 3, 4, 5 and 6amplitude of the oscillatory activity
functional brain MRIweek 1 and 6BOLD signal

Countries

France

Contacts

Primary ContactJean Christophe Corvol, MD, PHD
jean-christophe.corvol@aphp.fr01 42 16 57 72

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026